메뉴 건너뛰기




Volumn 309, Issue 21, 2013, Pages 2219-2220

Opioid analgesics - Risky drugs, not risky patients

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

EID: 84878602253     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.5794     Document Type: Short Survey
Times cited : (57)

References (10)
  • 2
    • 59049099592 scopus 로고    scopus 로고
    • The promotion and marketing of oxycontin: Commercial triumph, public health tragedy
    • Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221-227.
    • (2009) Am J Public Health , vol.99 , Issue.2 , pp. 221-227
    • Van Zee, A.1
  • 3
    • 0030897055 scopus 로고    scopus 로고
    • The use of opioids for the treatment of chronic pain: A consensus statement from the American Academy of Pain Medicine and the American Pain Society
    • The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain. 1997;13(1):6-8.
    • (1997) Clin J Pain , vol.13 , Issue.1 , pp. 6-8
  • 4
    • 84870720504 scopus 로고    scopus 로고
    • Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse
    • Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3)(suppl):ES67-ES92.
    • (2012) Pain Physician , vol.15 , Issue.3 SUPPL.
    • Sehgal, N.1    Manchikanti, L.2    Smith, H.S.3
  • 5
    • 84878525844 scopus 로고    scopus 로고
    • Published March 22, 2010. Accessed May 3, 2013
    • Purdue Pharma LP. Medication guide: OxyContin tablets. http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/ 022272s000remsOxycontin.pdf. Published March 22, 2010. Accessed May 3, 2013.
    • Medication Guide: OxyContin Tablets
    • Purdue Pharma, L.P.1
  • 6
    • 79960689551 scopus 로고    scopus 로고
    • Prevalence of prescription opioid-use disorder among chronic pain patients: Comparison of the DSM-5 vs. DSM-4 diagnostic criteria
    • Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30(3):185-194.
    • (2011) J Addict Dis , vol.30 , Issue.3 , pp. 185-194
    • Boscarino, J.A.1    Rukstalis, M.R.2    Hoffman, S.N.3
  • 8
    • 0024565001 scopus 로고
    • Opioid pseudoaddiction - An iatrogenic syndrome
    • DOI 10.1016/0304-3959(89)90097-3
    • Weissman DE, Haddox JD. Opioid pseudoaddiction - an iatrogenic syndrome. Pain. 1989;36(3):363-366. (Pubitemid 19077936)
    • (1989) Pain , vol.36 , Issue.3 , pp. 363-366
    • Weissman, D.E.1    Haddox, J.D.2
  • 9
    • 0034821970 scopus 로고    scopus 로고
    • Definitions related to the use of opioids for the treatment of pain
    • American Academy of Pain Medicine, the American Pain Society and the American Society of Addiction Medicine
    • American Academy of Pain Medicine, the American Pain Society and the American Society of Addiction Medicine. Definitions related to the use of opioids for the treatment of pain. WMJ. 2001;100(5):28-29.
    • (2001) WMJ , vol.100 , Issue.5 , pp. 28-29
  • 10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.